España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Quest Diagnostics
DGX
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$172.24
0.10
0.06%
At close: -
$172.24
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Quest Diagnostics (DGX) Forecast
News
Earnings
Quest Diagnostics (DGX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Quest Diagnostics (NYSE:DGX) Stock
Quest Diagnostics Stock (NYSE: DGX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, February 12, 2025
Grail Shares Spiked Wednesday: What's Going On?
Vaishali Prayag
GRAIL And Quest Diagnostics Provide GRAIL's G...
Benzinga Newsdesk
Tuesday, February 04, 2025
JP Morgan Maintains Neutral on Quest Diagnost...
Benzinga Newsdesk
Monday, February 03, 2025
Mizuho Maintains Outperform on Quest Diagnost...
Benzinga Newsdesk
UBS Maintains Neutral on Quest Diagnostics, R...
Benzinga Newsdesk
Piper Sandler Reiterates Neutral on Quest Dia...
Benzinga Newsdesk
Friday, January 31, 2025
What 6 Analyst Ratings Have To Say About Quest Diagnostics
Benzinga Insights
Truist Securities Maintains Hold on Quest Dia...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Quest Diag...
Benzinga Newsdesk
Thursday, January 30, 2025
Quest Diagnostics Delivers Q4 Earnings Beat: The Details
Adam Eckert
Earlier: Quest Diagnostics Sees FY25 Revenue ...
Benzinga Newsdesk
Reported Earlier, Quest Diagnostics Sees FY25...
Benzinga Newsdesk
Earlier: Quest Diagnostics Increased Its Quar...
Benzinga Newsdesk
IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Quest Diagnostics shares are trading higher f...
Benzinga Newsdesk
Quest Diagnostics Sees FY25 GAAP EPS $8.34-$8...
Benzinga Newsdesk
Quest Diagnostics Q4 2024 Adj EPS $2.23 Beats...
Benzinga Newsdesk
Earnings Scheduled For January 30, 2025
Benzinga Insights
Monday, January 06, 2025
Analyst Expectations For Quest Diagnostics's Future
Benzinga Insights
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Avi Kapoor
Leerink Partners Upgrades Quest Diagnostics t...
Benzinga Newsdesk
Tuesday, December 31, 2024
How Is The Market Feeling About Quest Diagnostics?
Benzinga Insights
Thursday, December 19, 2024
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh
Mainz Biomed Forms Agreement With Quest Diagn...
Benzinga Newsdesk
Tuesday, December 17, 2024
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Morgan Stanley Upgrades Quest Diagnostics to ...
Benzinga Newsdesk
Friday, December 13, 2024
B of A Securities Maintains Buy on Quest Diag...
Benzinga Newsdesk
Tuesday, December 10, 2024
The Analyst Landscape: 8 Takes On Quest Diagnostics
Benzinga Insights
Jefferies Assumes Quest Diagnostics at Buy, A...
Benzinga Newsdesk
Tuesday, December 03, 2024
Insider Activity Update: Catherine T Doherty Executes Options Exercise, Resulting In $1.89M At Quest Diagnostics
Benzinga Insights
Monday, December 02, 2024
(DGX) - Analyzing Quest Diagnostics's Short Interest
Benzinga Insights
Monday, November 11, 2024
How Is The Market Feeling About Quest Diagnostics?
Benzinga Insights
Saturday, November 09, 2024
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Vandana Singh
Thursday, October 31, 2024
Quest Diagnostics SVP Trades Company's Stock
Benzinga Insights
Monday, October 28, 2024
Piper Sandler Maintains Neutral on Quest Diag...
Benzinga Newsdesk
Thursday, October 24, 2024
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
Vandana Singh
Mizuho Maintains Outperform on Quest Diagnost...
Benzinga Newsdesk
Wednesday, October 23, 2024
UBS Maintains Neutral on Quest Diagnostics, R...
Benzinga Newsdesk
Citigroup Maintains Buy on Quest Diagnostics,...
Benzinga Newsdesk
This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Avi Kapoor
Barclays Maintains Equal-Weight on Quest Diag...
Benzinga Newsdesk
What Analysts Are Saying About Quest Diagnostics Stock
Benzinga Insights
Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics
Benzinga Insights
Quest Diagnostics Announced That It Has Been ...
Benzinga Newsdesk
Baird Upgrades Quest Diagnostics to Outperfor...
Benzinga Newsdesk
Tuesday, October 22, 2024
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
Vandana Singh
Quest Diagnostics shares are trading higher a...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch